{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T08:00:17Z","timestamp":1794988817006,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["425"],"award-info":[{"award-number":["425"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatoblastoma, the most prevalent pediatric liver cancer, almost always carries a WNT-activating\n                    <jats:italic>CTNNB1<\/jats:italic>\n                    mutation, yet exhibits notable molecular heterogeneity. To characterize this heterogeneity and identify novel targeted therapies, we perform comprehensive analysis of hepatoblastomas and tumor-derived organoids using single-cell RNA-seq\/ATAC-seq, spatial transcriptomics, and high-throughput drug profiling. We identify two distinct tumor epithelial signatures: hepatic \u2018fetal\u2019 and WNT-high \u2018embryonal\u2019, displaying divergent WNT signaling patterns. The fetal group is enriched for liver-specific WNT targets, while the embryonal group is enriched in canonical WNT target genes. Gene regulatory network analysis reveals enrichment of regulons related to hepatic functions such as bile acid, lipid and xenobiotic metabolism in the fetal subtype but not in the embryonal subtype. In addition, the dichotomous expression pattern of the transcription factors HNF4A and LEF1 allows for a clear distinction between the fetal and embryonal tumor cells. We also perform high-throughput drug screening using patient-derived tumor organoids and identify sensitivity to HDAC inhibitors. Intriguingly, embryonal and fetal tumor organoids are sensitive to FGFR and EGFR inhibitors, respectively, indicating a dependency on EGF\/FGF signaling in hepatoblastoma tumorigenesis. In summary, our data uncover the molecular and drug sensitivity landscapes of hepatoblastoma and pave the way for the development of targeted therapies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-52757-w","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:04:33Z","timestamp":1732079073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-480X","authenticated-orcid":false,"given":"Thomas A.","family":"Kluiver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6374-1357","authenticated-orcid":false,"given":"Yuyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-1350","authenticated-orcid":false,"given":"Stephanie A.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne J.","family":"Kraaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-4613","authenticated-orcid":false,"given":"Femke","family":"Ringnalda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-583X","authenticated-orcid":false,"given":"Philip","family":"Lijnzaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-4789","authenticated-orcid":false,"given":"Jeff","family":"DeMartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-3511","authenticated-orcid":false,"given":"Wouter L.","family":"Megchelenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Amo-Addae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Eising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia W.","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-0238","authenticated-orcid":false,"given":"Daniel","family":"M\u00fcnter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-9939","authenticated-orcid":false,"given":"Marc","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-8102","authenticated-orcid":false,"given":"Kornelius","family":"Kerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9450-5282","authenticated-orcid":false,"given":"Evelien","family":"Duiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius C.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-5917","authenticated-orcid":false,"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-3184","authenticated-orcid":false,"given":"Ruben H.","family":"de Kleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-2015","authenticated-orcid":false,"given":"Thanasis","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-1576","authenticated-orcid":false,"given":"Hendrik G.","family":"Stunnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3077-5582","authenticated-orcid":false,"given":"Hans","family":"Clevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-5458","authenticated-orcid":false,"given":"Weng Chuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"52757_CR1","unstructured":"Meyers, R. L., Aronson, D. C. & Zimmermann, A. Pediatric Surgery (Seventh Edition, 2012)."},{"key":"52757_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1093526619875228","volume":"23","author":"S Ranganathan","year":"2020","unstructured":"Ranganathan, S., Lopez-Terrada, D. & Alaggio, R. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr. Dev.Pathol. 23, 79\u201395 (2020).","journal-title":"Pediatr. Dev.Pathol."},{"key":"52757_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/ppe.12671","volume":"34","author":"P Dasgupta","year":"2020","unstructured":"Dasgupta, P. et al. Global trends in incidence rates of childhood liver cancers: A systematic review and meta\u2010analysis. Paediatr. Pe\u0301rinat. Epidemiol. 34, 609\u2013617 (2020).","journal-title":"Paediatr. Pe\u0301rinat. Epidemiol."},{"key":"52757_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros, J. et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 14, 834\u2013842 (2013).","journal-title":"Lancet Oncol."},{"key":"52757_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo, G. et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N. Engl. J. Med. 361, 1662\u20131670 (2009).","journal-title":"N. Engl. J. Med."},{"key":"52757_CR6","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zs\u00edros","year":"2010","unstructured":"Zs\u00edros, J. et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study. J. Clin. Oncol. 28, 2584\u20132590 (2010).","journal-title":"J. Clin. Oncol."},{"key":"52757_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-16-S2-P224","volume":"16","author":"V Moroz","year":"2015","unstructured":"Moroz, V. et al. The paediatric hepatic international tumour trial (PHITT): clinical trial design in rare disease. Trials 16, P224 (2015).","journal-title":"Trials"},{"key":"52757_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3390\/cancers11111777","volume":"11","author":"B Dembowska-Bagi\u0144ska","year":"2019","unstructured":"Dembowska-Bagi\u0144ska, B. et al. Health status in long-term survivors of hepatoblastoma. Cancers 11, 1777 (2019).","journal-title":"Cancers"},{"key":"52757_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Gr\u00f6bner","year":"2018","unstructured":"Gr\u00f6bner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321\u2013327 (2018).","journal-title":"Nature"},{"key":"52757_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller, M. et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J. Hepatol. 61, 1312\u20131320 (2014).","journal-title":"J. Hepatol."},{"key":"52757_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada, D. et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum. Pathol. 40, 783\u2013794 (2009).","journal-title":"Hum. Pathol."},{"key":"52757_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jpedsurg.2022.05.022","volume":"57","author":"SA Vasudevan","year":"2022","unstructured":"Vasudevan, S. A. et al. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children\u2019s Oncology Group Trial, AHEP0731. J. Pediatr. Surg. 57, 251\u2013256 (2022).","journal-title":"J. Pediatr. Surg."},{"key":"52757_CR13","doi-asserted-by":"publisher","unstructured":"Hiyama, E. Gene expression profiling in hepatoblastoma cases of the Japanese Study Group for Pediatric Liver Tumors-2 (JPLT-2) trial. https:\/\/doi.org\/10.31487\/j.ejmc.2018.01.003.","DOI":"10.31487\/j.ejmc.2018.01.003"},{"key":"52757_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-Catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471\u2013484 (2008).","journal-title":"Cancer Cell"},{"key":"52757_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin, P. et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65, 104\u2013121 (2017).","journal-title":"Hepatology"},{"key":"52757_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-0125-y","volume":"4","author":"M Sekiguchi","year":"2020","unstructured":"Sekiguchi, M. et al. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. Npj Precis. Oncol. 4, 20 (2020).","journal-title":"Npj Precis. Oncol."},{"key":"52757_CR17","doi-asserted-by":"publisher","first-page":"candisc.1809.20","DOI":"10.1158\/2159-8290.CD-20-1809","volume":"11","author":"TZ Hirsch","year":"2021","unstructured":"Hirsch, T. Z. et al. Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer. Cancer Discov. 11, candisc.1809.2020 (2021).","journal-title":"Cancer Discov."},{"key":"52757_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae, G. et al. Genetic and epigenetic basis of hepatoblastoma diversity. Nat. Commun. 12, 5423 (2021).","journal-title":"Nat. Commun."},{"key":"52757_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.29672","volume":"68","author":"KB Hooks","year":"2018","unstructured":"Hooks, K. B. et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 68, 89\u2013102 (2018).","journal-title":"Hepatology"},{"key":"52757_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach, J. et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J. Hepatol. 73, 328\u2013341 (2020).","journal-title":"J. Hepatol."},{"key":"52757_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat. Commun. 13, 4878 (2022).","journal-title":"Nat. Commun."},{"key":"52757_CR22","unstructured":"Huang, H. et al. Single\u2010cell transcriptomics uncovers cellular architecture and developmental Trajectories in hepatoblastoma. Hepatology (2022)."},{"key":"52757_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","volume":"10","author":"S Benhamouche","year":"2006","unstructured":"Benhamouche, S. et al. Apc tumor suppressor gene Is the \u201cZonation-Keeper\u201d of mouse liver. Dev. Cell 10, 759\u2013770 (2006).","journal-title":"Dev. Cell"},{"key":"52757_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cell.2020.09.012","volume":"183","author":"J Lotto","year":"2020","unstructured":"Lotto, J. et al. Single-cell transcriptomics reveals early emergence of liver parenchymal and non-parenchymal cell lineages. Cell 183, 702\u2013716 (2020).","journal-title":"Cell"},{"key":"52757_CR25","doi-asserted-by":"crossref","unstructured":"Wesley, B. T. et al. Single-cell atlas of human liver development reveals pathways directing hepatic cell fates. Nat. Cell Biol. 24, 1487\u20131498 (2022).","DOI":"10.1038\/s41556-022-00989-7"},{"key":"52757_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.onc.1208860","volume":"25","author":"C Cavard","year":"2006","unstructured":"Cavard, C. et al. Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with \u03b2-catenin mutations. Oncogene 25, 599\u2013608 (2006).","journal-title":"Oncogene"},{"key":"52757_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/labinvest.3700479","volume":"86","author":"PN Grozdanov","year":"2006","unstructured":"Grozdanov, P. N., Yovchev, M. I. & Dabeva, M. D. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor\/oval cells. Lab. Investig. 86, 1272\u20131284 (2006).","journal-title":"Lab. Investig."},{"key":"52757_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nature08875","volume":"464","author":"Y Shimomura","year":"2010","unstructured":"Shimomura, Y. et al. APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature 464, 1043\u20131047 (2010).","journal-title":"Nature"},{"key":"52757_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2016.12.042","volume":"390","author":"S Zeng","year":"2017","unstructured":"Zeng, S. et al. BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial\u2013mesenchymal transition via upregulating ID2. Cancer Lett. 390, 67\u201376 (2017).","journal-title":"Cancer Lett."},{"key":"52757_CR30","doi-asserted-by":"crossref","unstructured":"Wu, P. V. & Rangaswami, A. Current Approaches in Hepatoblastoma\u2014New Biological Insights to Inform Therapy. Curr. Oncol. Rep. 24, 1209\u20131218 (2022).","DOI":"10.1007\/s11912-022-01230-2"},{"key":"52757_CR31","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: Single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"52757_CR32","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.29353","volume":"66","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. A single\u2010cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation. Hepatology 66, 1387\u20131401 (2017).","journal-title":"Hepatology"},{"key":"52757_CR33","doi-asserted-by":"publisher","first-page":"e44126","DOI":"10.1371\/journal.pone.0044126","volume":"7","author":"S Kumari","year":"2012","unstructured":"Kumari, S., Mukhopadhyay, G. & Tyagi, R. K. Transcriptional regulation of mouse PXR Gene: An interplay of transregulatory factors. PLoS ONE 7, e44126 (2012).","journal-title":"PLoS ONE"},{"key":"52757_CR34","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/hep.26924","volume":"59","author":"A Gougelet","year":"2014","unstructured":"Gougelet, A. et al. T\u2010cell factor 4 and \u03b2\u2010catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 59, 2344\u20132357 (2014).","journal-title":"Hepatology"},{"key":"52757_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens, J. et al. Functional interaction of \u03b2-catenin with the transcription factor LEF-1. Nature 382, 638\u2013642 (1996).","journal-title":"Nature"},{"key":"52757_CR36","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek, V. et al. Constitutive transcriptional activation by a \u03b2-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma. Science 275, 1784\u20131787 (1997).","journal-title":"Science"},{"key":"52757_CR37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","volume":"275","author":"PJ Morin","year":"1997","unstructured":"Morin, P. J. et al. Activation of \u03b2-catenin-Tcf signaling in colon cancer by mutations in \u03b2-catenin or APC. Science 275, 1787\u20131790 (1997).","journal-title":"Science"},{"key":"52757_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cels.2023.06.004","volume":"14","author":"P Pagella","year":"2023","unstructured":"Pagella, P. et al. The time-resolved genomic impact of Wnt\/\u03b2-catenin signaling. Cell Syst. 14, 563\u2013581.e7 (2023).","journal-title":"Cell Syst."},{"key":"52757_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature21065","volume":"542","author":"KB Halpern","year":"2017","unstructured":"Halpern, K. B. et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352\u2013356 (2017).","journal-title":"Nature"},{"key":"52757_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199\u2013204 (2019).","journal-title":"Nature"},{"key":"52757_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/genes10010021","volume":"10","author":"A DeLaForest","year":"2018","unstructured":"DeLaForest, A. et al. HNF4A Regulates the formation of hepatic progenitor cells from human iPSC-derived endoderm by facilitating efficient recruitment of RNA Pol II. Genes 10, 21 (2018).","journal-title":"Genes"},{"key":"52757_CR42","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/emboj\/21.7.1782","volume":"21","author":"A Behrens","year":"2002","unstructured":"Behrens, A. et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c\u2010jun in the liver. Embo J. 21, 1782\u20131790 (2002).","journal-title":"Embo J."},{"key":"52757_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310 (2020).","journal-title":"Nat. Commun."},{"key":"52757_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109568","volume":"36","author":"C Calandrini","year":"2021","unstructured":"Calandrini, C. et al. Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors. Cell Rep. 36, 109568 (2021).","journal-title":"Cell Rep."},{"key":"52757_CR45","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-20-0666","volume":"20","author":"L Vernooij","year":"2021","unstructured":"Vernooij, L. et al. High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells. Mol. Cancer Ther. 20, 1161\u20131172 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"52757_CR46","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.3390\/cancers13236072","volume":"13","author":"M Bleijs","year":"2021","unstructured":"Bleijs, M. et al. EWSR1-WT1 Target genes and therapeutic options identified in a novel DSRCT in vitro model. Cancers 13, 6072 (2021).","journal-title":"Cancers"},{"key":"52757_CR47","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216001","volume":"14","author":"MT Meister","year":"2022","unstructured":"Meister, M. T. et al. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes. EMBO Mol. Med. 14, e16001 (2022).","journal-title":"EMBO Mol. Med."},{"key":"52757_CR48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/15384047.2016.1235664","volume":"17","author":"A Beck","year":"2016","unstructured":"Beck, A. et al. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. Cancer Biol. Ther. 17, 1168\u20131176 (2016).","journal-title":"Cancer Biol. Ther."},{"key":"52757_CR49","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.18632\/oncotarget.27237","volume":"10","author":"D Kats","year":"2019","unstructured":"Kats, D. et al. Volasertib preclinical activity in high-risk hepatoblastoma. Oncotarget 10, 6403\u20136417 (2019).","journal-title":"Oncotarget"},{"key":"52757_CR50","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/hep.31919","volume":"74","author":"ME Johnston","year":"2021","unstructured":"Johnston, M. E. et al. Olaparib inhibits tumor growth of hepatoblastoma in patient\u2010derived xenograft models. Hepatology 74, 2201\u20132215 (2021).","journal-title":"Hepatology"},{"key":"52757_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee, P. & Wang, Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers 9, 52 (2017).","journal-title":"Cancers"},{"key":"52757_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1359-6101(00)00014-9","volume":"11","author":"B Boilly","year":"2000","unstructured":"Boilly, B., Vercoutter-Edouart, A. S., Hondermarck, H., Nurcombe, V. & Bourhis, X. L. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 11, 295\u2013302 (2000).","journal-title":"Cytokine Growth Factor Rev."},{"key":"52757_CR53","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"27","author":"D L\u00f3pez-Terrada","year":"2014","unstructured":"L\u00f3pez-Terrada, D. et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod. Pathol. 27, 472\u2013491 (2014).","journal-title":"Mod. Pathol."},{"key":"52757_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dvdy.22041","volume":"239","author":"R Gebhardt","year":"2010","unstructured":"Gebhardt, R. & Hovhannisyan, A. Organ patterning in the adult stage: The role of Wnt\/\u03b2\u2010catenin signaling in liver zonation and beyond. Dev. Dyn. 239, 45\u201355 (2010).","journal-title":"Dev. Dyn."},{"key":"52757_CR55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep4.1196","volume":"2","author":"M Preziosi","year":"2018","unstructured":"Preziosi, M., Okabe, H., Poddar, M., Singh, S. & Monga, S. P. Endothelial Wnts regulate \u03b2\u2010catenin signaling in murine liver zonation and regeneration: A sequel to the Wnt\u2013Wnt situation. Hepatol. Commun. 2, 845\u2013860 (2018).","journal-title":"Hepatol. Commun."},{"key":"52757_CR56","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/hep.32328","volume":"76","author":"S Annunziato","year":"2022","unstructured":"Annunziato, S., Sun, T. & Tchorz, J. S. The RSPO\u2010LGR4\/5\u2010ZNRF3\/RNF43 module in liver homeostasis, regeneration, and disease. Hepatology 76, 888\u2013899 (2022).","journal-title":"Hepatology"},{"key":"52757_CR57","doi-asserted-by":"publisher","unstructured":"Wu, P. V. et al. Cholangiocytic differentiation drives cell proliferation in hepatoblastoma through Wnt-dependent FGF19 signaling. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.06.08.544267 (2023).","DOI":"10.1101\/2023.06.08.544267"},{"key":"52757_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/jhep.2003.50273","volume":"37","author":"AJ Watt","year":"2003","unstructured":"Watt, A. J., Garrison, W. D. & Duncan, S. A. HNF4: A central regulator of hepatocyte differentiation and function. Hepatology 37, 1249\u20131253 (2003).","journal-title":"Hepatology"},{"key":"52757_CR59","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1242\/dev.062547","volume":"138","author":"A DeLaForest","year":"2011","unstructured":"DeLaForest, A. et al. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 138, 4143\u20134153 (2011).","journal-title":"Development"},{"key":"52757_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng1175","volume":"34","author":"F Parviz","year":"2003","unstructured":"Parviz, F. et al. Hepatocyte nuclear factor 4\u03b1 controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 34, 292\u2013296 (2003).","journal-title":"Nat. Genet."},{"key":"52757_CR61","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH804>3.0.CO;2-R","volume":"193","author":"WS Park","year":"2001","unstructured":"Park, W. S. et al. Nuclear localization of \u03b2\u2010catenin is an important prognostic factor in hepatoblastoma. J. Pathol. 193, 483\u2013490 (2001).","journal-title":"J. Pathol."},{"key":"52757_CR62","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1242\/jcs.145136","volume":"126","author":"M Yang","year":"2013","unstructured":"Yang, M. et al. A double-negative feedback loop between Wnt\u2013\u03b2-catenin signaling and HNF4\u03b1 regulates epithelial\u2013mesenchymal transition in hepatocellular carcinoma. J. Cell Sci. 126, 5692\u20135703 (2013).","journal-title":"J. Cell Sci."},{"key":"52757_CR63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos, G. K. & Bhushan, B. Liver regeneration: biological and pathological mechanisms and implications. Nat. Rev. Gastroenterol. Hepatol. 18, 40\u201355 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"52757_CR64","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cell.2018.11.012","volume":"175","author":"WC Peng","year":"2018","unstructured":"Peng, W. C. et al. Inflammatory cytokine TNF\u03b1 promotes the long-term expansion of primary hepatocytes in 3D culture. Cell 175, 1607\u20131619 (2018).","journal-title":"Cell"},{"key":"52757_CR65","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/cancers12082294","volume":"12","author":"A Wagner","year":"2020","unstructured":"Wagner, A. et al. SP8 Promotes an aggressive phenotype in hepatoblastoma via FGF8 activation. Cancers 12, 2294 (2020).","journal-title":"Cancers"},{"key":"52757_CR66","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1128\/MCB.20.18.6882-6890.2000","volume":"20","author":"AN Billin","year":"2000","unstructured":"Billin, A. N., Thirlwell, H. & Ayer, D. E. \u03b2-Catenin\u2013histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol. Cell Biol. 20, 6882\u20136890 (2000).","journal-title":"Mol. Cell Biol."},{"key":"52757_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-1-2","volume":"1","author":"A Chi","year":"2013","unstructured":"Chi, A., Remick, S. & Tse, W. EGFR inhibition in non-small cell lung cancer: current evidence and future directions. Biomark. Res. 1, 2 (2013).","journal-title":"Biomark. Res."},{"key":"52757_CR68","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.3390\/cancers13122968","volume":"13","author":"A Kommalapati","year":"2021","unstructured":"Kommalapati, A., Tella, S. H., Borad, M., Javle, M. & Mahipal, A. FGFR Inhibitors in oncology: Insight on the management of toxicities in clinical practice. Cancers 13, 2968 (2021).","journal-title":"Cancers"},{"key":"52757_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"A Suraweera","year":"2018","unstructured":"Suraweera, A., O\u2019Byrne, K. J. & Richard, D. J. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi. Front. Oncol. 8, 92 (2018).","journal-title":"Front. Oncol."},{"key":"52757_CR70","doi-asserted-by":"publisher","first-page":"e0270854","DOI":"10.1371\/journal.pone.0270854","volume":"17","author":"N Maouche","year":"2022","unstructured":"Maouche, N. et al. Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort. PLoS ONE 17, e0270854 (2022).","journal-title":"PLoS ONE"},{"key":"52757_CR71","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/cancers12092668","volume":"12","author":"JA Saltsman","year":"2020","unstructured":"Saltsman, J. A. et al. A Human organoid model of aggressive hepatoblastoma for disease modeling and drug testing. Cancers 12, 2668 (2020).","journal-title":"Cancers"},{"key":"52757_CR72","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-0716-2557-6_19","volume":"2544","author":"PV Wu","year":"2022","unstructured":"Wu, P. V. & Nusse, R. Hepatocytes, methods and protocols. Methods Mol. Biol. 2544, 259\u2013267 (2022).","journal-title":"Methods Mol. Biol."},{"key":"52757_CR73","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.stem.2020.07.020","volume":"27","author":"Y Miao","year":"2020","unstructured":"Miao, Y. et al. Next-generation surrogate Wnts support organoid growth and deconvolute frizzled pleiotropy in vivo. Cell Stem Cell 27, 840\u2013851 (2020).","journal-title":"Cell Stem Cell"},{"key":"52757_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2557-6_1","volume":"2544","author":"TA Kluiver","year":"2022","unstructured":"Kluiver, T. A., Kraaier, L. J. & Peng, W. C. Hepatocytes, methods and protocols. Methods Mol. Biol. 2544, 1\u201313 (2022).","journal-title":"Methods Mol. Biol."},{"key":"52757_CR75","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"52757_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1950-6","volume":"21","author":"S Yang","year":"2020","unstructured":"Yang, S. et al. Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 21, 57 (2020).","journal-title":"Genome Biol."},{"key":"52757_CR77","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper, M. et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat. Med. 26, 792\u2013802 (2020).","journal-title":"Nat. Med."},{"key":"52757_CR78","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2023.11.004","volume":"186","author":"X Qin","year":"2023","unstructured":"Qin, X. et al. An oncogenic phenoscape of colonic stem cell polarization. Cell 186, 5554\u20135568 (2023).","journal-title":"Cell"},{"key":"52757_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"52757_CR80","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52757-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T10:03:33Z","timestamp":1732269813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52757"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52757-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.C. is currently head of pharma Research Early Development (pRED) at Roche and is an inventor on several patents related to organoid technology. His full disclosure is given at\n                      \n                      . The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8576"}}